Ankur Sharma
Ankur obtained his Ph.D. from the Indian Institute of Science, Bangalore. In 2015, he joined the Genome Institute of Singapore (GIS) and employed single-cell genomics to explore tumor evolution and ecosystem, focusing on tumor-immune interactions. His early work leads to the discovery of drug-induced infidelity in the stem-cell hierarchy in head and neck cancers. More recently, he discovered the phenomenon of oncofetal reprogramming in the tumor ecosystem (Cell 2020). In 2019, he secured the NMRC Young Investigator grant to work on the mechanism of immune escape in triple-negative breast cancers. In 2020, he was appointed as Research Scientist at Spatial and Single Cell Systems Domain at GIS, A*-star. He is also a member of the multidisciplinary Human Cell Atlas (HCA) liver team and among the first members of the 10x Genomics Clinical Translational Research Network (CTRN). From early 2021, he will start as Laboratory Head at Harry Perkins Institute of Medical Research and women’s cancer senior fellow/Senior lecture at Curtin Health Innovation Research Institute (CHIRI), Curtin University, Perth, Western Australia. His upcoming laboratory at Perth focuses on the triquetra of early development, regeneration, and cancer. He is combining single-cell genomics, spatial transcriptomics, and machine learning approaches to understand the developmental/embryonic origins of cancers.
Abstracts this author is presenting: